Announcements Trials

Browse Landscape

Status

Recruiting 5 Completed 3 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

pembrolizumab 111 Carboplatin 45 Nivolumab 41 Paclitaxel 34 Cyclophosphamide 32 Cisplatin 32 Gemcitabine 30 atezolizumab 27 venetoclax 25 Specimen Handling 25 Magnetic Resonance Spectroscopy 24 Pemetrexed 23 fludarabine 22 Docetaxel 22 Biopsy 22 Radiotherapy 21 Ipilimumab 21 Bevacizumab 21 Azacitidine 21 Radiosurgery 18 Dexamethasone 18 durvalumab 17 Fluorouracil 17 Cetuximab 16 fludarabine phosphate 14 Trastuzumab 14 tislelizumab 13 Leucovorin 13 Cytarabine 13 olaparib 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Urine Specimen Collection × 1 year × Clear all

NCT04111809 2025-09-25

AMBROBiMM

Assistance Publique - Hôpitaux de Paris

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡